# Haplo-HSCT for Myelofibrosis

> **NCT06674382** · NA · RECRUITING · sponsor: **Peking University People's Hospital** · enrollment: 39 (estimated)

## Conditions studied

- Myelofibrosis

## Interventions

- **PROCEDURE:** Haploidentical hematopoietic stem cell transplantation

## Key facts

- **NCT ID:** NCT06674382
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 39 (ESTIMATED)
- **Last updated:** 2025-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06674382

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06674382, "Haplo-HSCT for Myelofibrosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06674382. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*